Bone turnover across the menopause transition: Correlations with inhibins and follicle-stimulating hormone

Journal of Clinical Endocrinology and Metabolism

Volumn 91, Issue 5, 2006, Pages 1848-1854

  Perrien, Daniel S ^a   Achenbach, Sara J ^b   Bledsoe, Samuel E ^a   Walser, Brandon ^a   Suva, Larry J ^a   Khosla, Sundeep ^b   Gaddy, Dana ^a,c  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b MAYO CLINIC   (United States)

^c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOLLITROPIN; INHIBIN A; INHIBIN B;

ADULT; ARTICLE; BONE TURNOVER; CONTROLLED STUDY; FEMALE; HORMONE SUBSTITUTION; HUMAN; HUMAN EXPERIMENT; MENOPAUSE; OSSIFICATION; OSTEOLYSIS; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; AGING; ALKALINE PHOSPHATASE; BIOLOGICAL MARKERS; BONE AND BONES; BONE RESORPTION; CALCIFICATION, PHYSIOLOGIC; CARRIER PROTEINS; CELL SEPARATION; CELLS, CULTURED; COLLAGEN TYPE I; ESTRADIOL; FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; INHIBINS; MEMBRANE GLYCOPROTEINS; MENOPAUSE; MIDDLE AGED; RADIOIMMUNOASSAY; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B;

EID: 33646429482     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2005-2423     Document Type: Article

References (33)

1. Manolagas SC 2000 Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev 21:115-137
2. Citron JT, Ettinger B, Genant HK 1995 Spinal bone mineral loss in estrogenreplete, calcium-replete premenopausal women. Osteoporos Int 5:228-233
3. Parfitt AM, Mathews CH, Villanueva AR, Kleerekoper M, Frame B, Rao DS 1983 Relationships between surface, volume, and thickness of iliac trabecular bone in aging and in osteoporosis. Implications for the microanatomic and cellular mechanisms of bone loss. J Clin Invest 72:1396-1409
4. Martin TJ, Ng KW 1994 Mechanisms by which cells of the osteoblast lineage control osteoclast formation and activity. J Cell Biochem 56:357-366
5. Riggs BL, Khosla S, Melton Jr L 2002 Sex steroids and the construction and conservation of the adult skeleton. Endocr Rev 23:279-302
6. Rosen CJ 2005 Clinical practice. Postmenopausal osteoporosis. N Engl J Med 353:595-603
7. Khosla S, Melton 3rd LJ, Atkinson EJ, O'Fallon WM, Klee GG, Riggs BL 1998 Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: a key role for bioavailable estrogen. J Clin Endocrinol Metab 83:2266-2274
8. Khosla S, Atkinson EJ, Melton 3rd LJ, Riggs BL 1997 Effects of age and estrogen status on serum parathyroid hormone levels and biochemical markers of bone turnover in women: a population-based study. J Clin Endocrinol Metab 82:1522-1527
9. Ebeling PR, Atley LM, Guthrie JR, Burger HG, Dennerstein L, Hopper JL, Wark JD 1996 Bone turnover markers and bone density across the menopausal transition. J Clin Endocrinol Metab 81:3366-3371
10. Klein NA, Illingworth PJ, Groome NP, McNeilly AS, Battaglia DE, Soules MR 1996 Decreased inhibin B secretion is associated with the monotropic FSH rise in older, ovulatory women: a study of serum and follicular fluid levels of dimeric inhibin A and B in spontaneous menstrual cycles. J Clin Endocrinol Metab 81:2742-2745
11. Welt CK, McNicholl DJ, Taylor AE, Hall JE 1999 Female reproductive aging is marked by decreased secretion of dimeric inhibin. J Clin Endocrinol Metab 84:105-111
12. Guthrie JR, Ebeling PR, Hopper JL, Barrett-Connor E, Dennerstein L, Dudley EC, Burger HG, Wark JD 1998 A prospective study of bone loss in menopausal Australian-born women. Osteoporos Int 8:282-290
13. Vale W, Bilezikjian LM, Rivier C 1994 Reproductive and other roles of inhibins and activins. In: Knobil E, Neil JD, eds. The physiology of reproduction. New York: Raven Press; 1861-1878
14. Inoue S, Nomura S, Hosoi T, Ouchi Y, Orimo H, Muramatsu M 1994 Localization of follistatin, an activin-binding protein, in bone tissues. Calcif Tissue Int 55:395-397
15. Funaba M, Ogawa K, Murata T, Fujimura H, Murata E, Abe M, Takahashi M, Torii K 1996 Follistatin and activin in bone: expression and localization during endochondral bone development. Endocrinology 137:4250-4259
16. Oue Y, Kanatani H, Kiyoki M, Eto Y, Ogata E, Matsumoto T 1994 Effect of local injection of activin A on bone formation in newborn rats. Bone 15:361-366
17. Broxmeyer HE, Lu L, Cooper S, Schwall RH, Mason AJ, Nikolics K 1988 Selective and indirect modulation of human multipotential and erythroid hematopoietic progenitor cell proliferation by recombinant human activin and inhibin. Proc Natl Acad Sci USA 85:9052-9056
18. Fujimoto K, Kawakita M, Kato K, Yonemura Y, Masuda T, Matsuzaki H, Hirose J, Isaji M, Sasaki H, Inoue T, Takatsuki K 1991 Purification of megakaryocyte differentiation activity from a human fibrous histiocytoma cell line: N-terminal sequence homology with activin A. Biochem Biophys Res Commun 174:1163-1168
19. Yu J, Shao LE, Lemas V, Yu AL, Vaughan J, Rivier J, Vale W 1987 Importance of FSH-releasing protein and inhibin in erythrodifferentiation. Nature 330:765-767
20. Gaddy-Kurten D, Coker JK, Abe E, Jilka RL, Manolagas SC 2002 Inhibin suppresses and activin stimulates osteoblastogenesis and osteoclastogenesis in murine bone marrow cultures. Endocrinology 143:74-83
21. Meunier H, Rivier C, Evans RM, Vale W 1988 Gonadal and extragonadal expression of inhibin α, β A, and β B subunits in various tissues predicts diverse functions. Proc Natl Acad Sci USA 85:247-251
22. Khosla S, Atkinson EJ, Riggs BL, Melton 3rd LJ 1996 Relationship between body composition and bone mass in women. J Bone Miner Res 11:857-863
23. Kurland LT, Molgaard CA 1981 The patient record in epidemiology. Sci Am 245:54-63
24. Bendre MS, Montague DC, Peery T, Akel NS, Gaddy D, Suva LJ 2003 Interleukin-8 stimulation of osteoclastogenesis and bone resorption is a mechanism for the increased osteolysis of metastatic bone disease. Bone 33:28-37
25. Riggs BL, Melton LJ, Oberg AL, Atkinson EJ, Khosla S 2005 Substantial trabecular bone loss occurs in young adult women and men: a population-based longitudinal study. J Bone Miner Res 20:S4
26. Klein NA, Soules MR 1998 Endocrine changes of the perimenopause. Clin Obstet Gynecol 41:912-920
27. Zhang Z, Sun L, Peng Y, Iqbal J, Zaidi S, Papachristou DJ, Zhou H, Sharrow AC, Yaroslavskiy BB, Zhu L, Zallone A, Sairam MR, Kumar TR, Cordoso-Landa L, Schaffler MB, Moonga BS, Blair HC, Zaidi M 2005 The pituitary hormone, FSH, directly enhances osteoclast formation and survival. J Bone Miner Res 20:S26
28. Akel NS, Perrien DS, Nicks KM, Gaddy D 2005 Bone anabolic effects of inhibin A are not mediated by direct effects of FSH and LH on bone marrow cells. J Bone Miner Res 20:S247
29. Martin TJ 2005 Osteoblast-derived PTHrP is a physiological regulator of bone formation. J Clin Invest 115:2322-2324
30. Burger HG 1999 The endocrinology of the menopause. J Steroid Biochem Mol Biol 69:31-35
31. Danforth DR, Arbogast LK, Mroueh J, Kim MH, Kennard EA, Seifer DB, Friedman CI 1998 Dimeric inhibin: a direct marker of ovarian aging. Fertil Steril 70:119-123
32. Klein NA, Battaglia DE, Miller PB, Branigan EF, Giudice LC, Soules MR 1996 Ovarian follicular development and the follicular fluid hormones and growth factors in normal women of advanced reproductive age. J Clin Endocrinol Metab 81:1946-1951
33. Abe E, Yamamoto M, Taguchi Y, Lecka-Czernik B, O'Brien CA, Economides AN, Stahl N, Jilka RL, Manolagas SC 2000 Essential requirement of BMPs-2/4 for both osteoblast and osteoclast formation in murine bone marrow cultures from adult mice: antagonism by noggin. J Bone Miner Res 15:663-673